Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, in an all-cash transaction. LGC Standards is a division of LGC Group, a global leader in life sciences, diagnostics, and analytical solutions. The LGC Standards business provides reference materials, research chemicals, and proficiency testing to ensure accuracy and reliability in laboratories and manufacturing.
Read the full article: Niagen Bioscience to Streamline and Focus Its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction //
Source: https://www.businesswire.com/news/home/20260226997493/en/Niagen-Bioscience-to-Streamline-and-Focus-its-Operations-with-the-Sale-of-ChromaDex-Reference-Standards-Business-to-LGC-in-All-Cash-Transaction